Jingjia subsidiary receives tobacco production license for electronic cigarettes

Aug.08.2022
Jinjia Holdings' subsidiary received a tobacco production license for electronic cigarettes, expanding their capabilities in the industry.

On the evening of August 4, Jingjia Co., Ltd. (002191) announced that its controlling subsidiary, Shenzhen Yunpu Xinghe Technology Service Co., Ltd. (hereinafter referred to as "Yunpu Xinghe"), received a tobacco monopoly production enterprise license (OEM) issued by the State Tobacco Monopoly Administration.


It is understood that Yunpuxinghe mainly provides one-stop production and processing, assembly and supply chain services for electronic cigarette brand customers. Currently, they operate in a 20,000 square-meter research and production facility located in the Jingjia Industrial Park in Shenzhen.


Jingjia Corporation announced that in the future, Yunpuxinghe will rely on the accumulated advantages of resources, technology, team, and other comprehensive advantages to provide electronic cigarette and pod production and processing services to customers. This will have a positive impact on advancing the development of the new tobacco industry and the future production and operation of the company.


This is the second license obtained by Jinjia as of now. In July, another subsidiary company of Jinjia, Yunnan Yunshuo Technology Co., Ltd. ("Yunshuo Technology"), received a tobacco monopoly production enterprise license (aerosol) from the State Tobacco Monopoly Administration. As one of the first companies in Yunnan Province to obtain a tobacco monopoly production enterprise license (aerosol production enterprise), Yunshuo Technology will expand the research and development, production and sales of electronic cigarette e-liquid and other products within the scope of this license.


As we enter August, there is less than two months left until the end of the transition period for new regulations on electronic cigarettes. The issuance of tobacco production licenses has become increasingly frequent, and it appears that Jianjia Holdings may also receive a license in the near future.


It is understood that Jing Jia Group has laid out its involvement in the entire platform of the new tobacco industry chain.


Upstream, there is a strategic focus on vape oil, heat-not-burn (HNB) flavors and fragrances, and new materials with two companies in this space - Yunshuo Technology and Changyi Technology. Yunshuo Technology is primarily involved in the research and development, production, and sales of traditional tobacco flavors and fragrances, as well as vape oil with a client base that includes several Chinese tobacco companies. Changyi Technology has carved out a stake in the HNB flavors and fragrances sector, as well as related new materials.


In the midstream sector, there are several companies providing original design manufacturing (ODM) services for renowned domestic and international electronic cigarette brands. Some major players in this market include Jingjia Technology, which specializes in ODM/OEM production, as well as Yunpu Xinghe and several others.


In downstream news, FOOGO (Innovation Flavors Technology), a new tobacco brand, has been achieving positive reviews and making strides in market expansion with its electronic cigarette products. Meanwhile, Yunpu Xinghe in Shenzhen and Indonesia is providing a new tobacco supply chain service for customers domestically and overseas. Hong Kong's Hengtian Commercial is primarily responsible for tobacco and related products in import/export trade and overseas promotion.


Jingjia Corporation and several of its subsidiary companies are in the process of applying for various licenses. Currently, they have obtained licenses for producing vaporized substances and manufacturing electronic cigarettes through subcontractors. If their brand license application is approved, Jingjia Corporation will become the first listed company with complete involvement in the electronic cigarette industry chain.


Jiangjia Corporation announced that it is continually improving its service chain in the industry to offer clients a range of services including tobacco extracts, flavorings, ODM, assembly, import and export, customs clearance and logistics. The company is committed to becoming a comprehensive service provider in the tobacco related industry, possessing advanced design and research and development techniques, excellent production and manufacturing capabilities, and complete service capacity.


With the implementation of domestic e-cigarette policy measures being steadily promoted, the industry policies are becoming clearer, and the e-cigarette industry in China has officially entered a new era of regulated development with established rules.


Tianfeng Securities believes that the regulatory policies are raising industry barriers by directly setting standards for electronic cigarettes, increasing the difficulties in product research and development and production. Companies engaged in the electronic cigarette business must obtain approval from the tobacco monopoly administrative authorities. Leading companies will have an advantage in future industry development, benefiting from the growth of the industry, and there is a possibility for a continued dominance by a small number of strong brands and producers.


Jingjia Technology, which has a complete industrial chain, is expected to take a leading position in the new market.


This article has quoted or reprinted information from third-party sources, and the copyright belongs to the original media and author. If there is any infringement, please contact us to delete it. Any organization or individual who wishes to reprint it, please contact the author and do not re-post directly.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
Product | KIWI Launches Spark 2 and Spark 2 Pro in Germany, Two Hardware Tiers Share Backward-Compatible 2ml Pods
KIWI has launched the Spark 2 and Spark 2 Pro refillable pod systems in Germany at official prices of €18 and €29, respectively. Spark 2 uses an 800mAh removable lithium-ion battery in a pen-style body, while Spark 2 Pro features a 1,400mAh removable battery, a box-shaped design and vibration feedback every 20 puffs. Both devices use the same 2ml Spark V2 pods in 0.8Ω and 1.2Ω versions, with AirSync airflow adjustment and a choice between Cotton Tips and conventional Drip Tips. The new pods also remain compatible with the original KIWI Spark.
News
Sep.29 by 2Firsts Perspectives
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09